Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

Undetectable ctDNA at baseline predicts superior prognosis in mCRPC, suggesting potential for treatment de-escalation and less intensive monitoring for this subgroup of patients. This trial is registered on ClinicalTrials.gov as NCT03903835.

Authors

Institutions

Publication Details

Journal
European Urology Oncology
Published
2025-04-21
DOI
https://doi.org/10.1016/j.euo.2025.02.002
Citations
4
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
6.07
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

Sanne D’hondt, Camilla Thellenberg‐Karlsson, Ashkan Mortezavi, Maria Persson et al.
4 citations
European Urology Oncology
Prostate Cancer Treatment and Research
6.07
article

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

Sanne D’hondt, Camilla Thellenberg‐Karlsson, Ashkan Mortezavi, Maria Persson, Jochen Darras, S. Johansson, Henrik Grönberg, Ingrida Verbiené, Johan Sandzén, Michiel Strijbos, Johan Lindberg, Daan De Maeseneer, Christophe Ghysel, Bram De Laere, Peter Schatteman, Siska Van Bruwaene, Gunilla Enblad, Martin Eklund, Brieuc Sautois, Mats Anden, Daisy Luyten, Piet Ost, Wendy De Roock, Nicolaas Lumen, Elin Jänes, Marie Hjälm-Eriksson, Anders Ullén, Els Everaert, Alessio Crippa, Jan Oldenburg, Andrea Discacciati, Martha Olsson, Berit Larsson, Linn Pettersson
article en
4 citations

Abstract

Undetectable ctDNA at baseline predicts superior prognosis in mCRPC, suggesting potential for treatment de-escalation and less intensive monitoring for this subgroup of patients. This trial is registered on ClinicalTrials.gov as NCT03903835.

European Urology OncologyVol. 8(6)
Karolinska University Hospital (SE), Uppsala University Hospital (SE), Science for Life Laboratory (SE), Akershus University Hospital (NO), AZ Groeninge (BE), Ghent University Hospital (BE), Karolinska Institutet (SE), Jessa Hospital (BE), Saint Göran Hospital (SE), University Hospital of Zurich (CH), Onze Lieve Vrouwziekenhuis Hospital (BE), Karlstad Central Hospital (SE), Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE), Damiaan Dicht bij het leven (BE), Länssjukhuset i Kalmar (SE), Centrallasarettet Växjö (SE), Ziekenhuis Oost-Limburg (BE), AZ Sint-Lucas (BE), Umeå University (SE)
Good health and well-being
Openalex Percentile: Top 4%
Prostate Cancer Treatment and Research
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.